HER2 status can be determined using a variety of diagnostic tests, primarily Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH). IHC measures the amount of HER2 protein on the surface of cells, while FISH assesses the number of copies of the HER2 gene within cancer cells. These tests help to classify the cancer and tailor appropriate treatment strategies.
